首页> 外文期刊>Pediatrics Neonatology >Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis
【24h】

Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis

机译:过敏性紫癜性肾炎患儿尿单核细胞趋化蛋白-1水平升高

获取原文
           

摘要

Background Chemokine monocyte chemoattractant protein-1 (MCP-1) has been proved as a potential urinary biomarker in nephropathies. The aim of this study was to investigate the urinary monocyte chemoattractant protein-1 (MCP-1) levels and clinical significance in Henoch-Schonlein purpura (HSP) children with and without nephritis and determine the association of MCP-1 with proteinuria. Methods A total of 261 HSP children—with or without nephritis—and 84 healthy control children were enrolled in this study. Of these, 126 HSP nephritis (HSPN) children were subdivided into three groups according to total urine protein in 24?h (TUP): Group A, mild proteinuria group with TUP 25?mg/kg; Group B, moderate proteinuria group with TUP ≥25?mg/kg and 50?mg/kg; Group C, severe proteinuria group with TUP ≥50?mg/kg. Urinary MCP-1 levels were determined by ELISA. Levels of serum creatinine (Cr), blood urea nitrogen (BUN), urinary α1-micro globulin (α1-MG), micro-albumin (mAlb), immunoglobulin G (IgG), transferrin (TRF) and TUP were performed to determine their associations with MCP-1. Results Urinary MCP-1 was significantly higher in HSPN group in comparison with HSP group and controls (P??0.05), but no significant difference was found between the HSP group and the healthy group (P??0.05). The levels of urinary MCP-1 increased in parallel to the enhancement of total urine protein in 24?h in HSPN patients. There were statistically significant differences among these three groups of HSPN children (p??0.05). Urinary MCP-1 correlated positively with urinary α1-MG, mAlb, IgG, TRF and TUP in HSPN, whereas no correlation was observed with serum Cr and BUN. Conclusions MCP-1 was elevated in children with HSPN and correlated with proteinuria. Urinary MCP-1 could be used as a suitable, non-invasive biomarker to provide valuable information not only for the diagnosis of HSPN, but also for evaluation of severity of renal damage.
机译:背景趋化因子单核细胞趋化蛋白1(MCP-1)已被证明是肾病中潜在的尿液生物标志物。这项研究的目的是调查患有和不患有肾炎的过敏性紫癜(HSP)患儿的尿单核细胞趋化蛋白-1(MCP-1)水平及其临床意义,并确定MCP-1与蛋白尿的关系。方法本研究共纳入261名HSP儿童(有或没有肾炎)和84名健康对照儿童。其中126例HSP肾炎(HSPN)儿童根据24小时尿液中总尿蛋白(TUP)分为三组:A组,TUP <25μmg/ kg的轻度蛋白尿组。 B组,中度蛋白尿组,TUP≥25?mg / kg且<50?mg / kg; C组,重度蛋白尿组,TUP≥50?mg / kg。通过ELISA测定尿中MCP-1水平。血清肌酐(Cr),血尿素氮(BUN),尿中α 1 -微球蛋白(α 1 -MG),微量白蛋白(mAlb),免疫球蛋白的水平进行G(IgG),转铁蛋白(TRF)和TUP以确定它们与MCP-1的关联。结果HSPN组尿MCP-1水平明显高于HSP组和正常对照组(P <0.05),而HSP组和健康组之间无显着性差异(P> 0.05)。 HSPN患者24小时内尿中MCP-1的水平增加与总尿蛋白的增加平行。这三组HSPN儿童之间有统计学差异(p <0.05)。尿MCP-1与HSPN中尿α 1 -MG,mAb,IgG,TRF和TUP呈正相关,而血清Cr和BUN则无相关性。结论HSPN患儿MCP-1升高,与蛋白尿有关。尿MCP-1可用作合适的非侵入性生物标志物,不仅可为HSPN的诊断提供有价值的信息,还可为评估肾损害的严重性提供有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号